SCHEMBL31439600

SCHEMBL31439600

CC(C)Oc1ccc(C(=O)Cn2nccn2)cc1[N+](=O)[O-]

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PDK1 Q15118 1/20 0.58
▸ XDH P47989 1/20 0.44
▸ POLB P06746 1/20 0.43
▸ ALDH1A1 P00352 5/20 0.43
▸ LMNA P02545 2/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ PDE4B Q07343 1/20 0.42
▸ KMT2A Q03164 3/20 0.41
▸ EP300 Q09472 1/20 0.40
▸ HIF1A Q16665 1/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ AGTR1 P30556 1/20 0.40
▸ THRA P10827 1/20 0.40
▸ THRB P10828 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31439550 0.82 PDK1 (0.54) PDK1XDHPOLBALDH1A1LMNA
SCHEMBL20033132 0.82 CYP19A1 (0.58) PDK1ALDH1A1LMNASMN1; SMN2KDM4E
SCHEMBL31439512 0.81 PDE4B (0.46) XDHPOLBALDH1A1LMNASMN1; SMN2
SCHEMBL31439477 0.81 PDE4B (0.43) POLBALDH1A1LMNASMN1; SMN2PDE4B
SCHEMBL16924930 0.80 PDK1 (0.66) PDK1XDHPOLBALDH1A1LMNA
SCHEMBL16924922 0.80 PDK1 (0.70) PDK1XDHPOLBALDH1A1LMNA
SCHEMBL31439516 0.80 PRSS1 (0.41) POLBALDH1A1LMNASMN1; SMN2KMT2A
SCHEMBL18232134 0.80 PDK1 (0.56) PDK1POLBALDH1A1LMNASMN1; SMN2
SCHEMBL20033128 0.79 PDK1 (0.55) PDK1POLBALDH1A1LMNASMN1; SMN2
Hydrochloric Acid SCHEMBL31439598 0.78 PDK1 (0.54) PDK1XDHPOLBALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025015167-A2 ERASTIN KETONE ANALOGS AND USES THEREOF EXARTA THERAPEUTICS, INC. (US) 2025-01-16 — — WO disclosed
Send feedback